Ropes Wealth Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $325K | Sell |
3,187
-179
| -5% | -$18.2K | 0.06% | 203 |
|
|
2023
Q2 | $340K | Sell |
3,366
-570
| -14% | -$57K | 0.06% | 212 |
|
|
2023
Q1 | $362K | Sell |
3,936
-407
| -9% | -$35.5K | 0.07% | 200 |
|
|
2022
Q4 | $394K | Buy |
4,343
+250
| +6% | +$21.1K | 0.07% | 189 |
|
|
2022
Q3 | $311K | Sell |
4,093
-1,065
| -21% | -$88.3K | 0.07% | 190 |
|
|
2022
Q2 | $436K | Hold |
5,158
| – | – | 0.09% | 183 |
|
|
2022
Q1 | $453K | Sell |
5,158
-246
| -5% | -$21.3K | 0.08% | 202 |
|
|
2021
Q4 | $473K | Sell |
5,404
-315
| -6% | -$26.2K | 0.08% | 172 |
|
|
2021
Q3 | $468K | Sell |
5,719
-150
| -3% | -$13.5K | 0.08% | 179 |
|
|
2021
Q2 | $535K | Hold |
5,869
| – | – | 0.08% | 170 |
|
|
2021
Q1 | $513K | Buy |
5,869
+462
| +9% | +$41.5K | 0.09% | 165 |
|
|
2020
Q4 | $511K | Sell |
5,407
-527
| -9% | -$46K | 0.08% | 152 |
|
|
2020
Q3 | $516K | Buy |
5,934
+1
| +0% | +$87 | 0.1% | 143 |
|
|
2020
Q2 | $518K | Buy |
5,933
+78
| +1% | +$6.73K | 0.11% | 132 |
|
|
2020
Q1 | $483K | Buy |
5,855
+667
| +13% | +$59.5K | 0.12% | 117 |
|
|
2019
Q4 | $491K | Sell |
5,188
-772
| -13% | -$69.3K | 0.11% | 142 |
|
|
2019
Q3 | $518K | Buy |
5,960
+992
| +20% | +$89.1K | 0.11% | 134 |
|
|
2019
Q2 | $454K | Sell |
4,968
-686
| -12% | -$58.1K | 0.1% | 149 |
|
|
2019
Q1 | $487K | Hold |
5,654
| – | – | 0.13% | 142 |
|
|
2018
Q4 | $435K | Sell |
5,654
-319
| -5% | -$24.8K | 0.13% | 142 |
|
|
2018
Q3 | $461K | Sell |
5,973
-502
| -8% | -$37.1K | 0.11% | 153 |
|
|
2018
Q2 | $438K | Buy |
6,475
+430
| +7% | +$29.7K | 0.12% | 146 |
|
|
2018
Q1 | $438K | Sell |
6,045
-23
| -0.4% | -$1.75K | 0.12% | 144 |
|
|
2017
Q4 | $456K | Sell |
6,068
-841
| -12% | -$63.5K | 0.12% | 147 |
|
|
2017
Q3 | $531K | Buy |
6,909
+446
| +7% | +$33.7K | 0.14% | 130 |
|
|
2017
Q2 | $483K | Buy |
6,463
+516
| +9% | +$36.6K | 0.14% | 135 |
|
|
2017
Q1 | $396K | Hold |
5,947
| – | – | 0.11% | 151 |
|
|
2016
Q4 | $388K | Buy |
5,947
+936
| +19% | +$60.7K | 0.12% | 145 |
|
|
2016
Q3 | $355K | Buy |
5,011
+168
| +3% | +$12.2K | 0.12% | 146 |
|
|
2016
Q2 | $358K | Sell |
4,843
-6,307
| -57% | -$436K | 0.12% | 137 |
|
|
2016
Q1 | $724K | Buy |
11,150
+1,004
| +10% | +$68.3K | 0.32% | 64 |
|
|
2015
Q4 | $782K | Hold |
10,146
| – | – | 0.34% | 60 |
|
|
2015
Q3 | $836K | Buy |
10,146
+3,673
| +57% | +$327K | 0.44% | 46 |
|
|
2015
Q2 | $570K | Sell |
6,473
-768
| -11% | -$70.5K | 0.31% | 63 |
|
|
2015
Q1 | $640K | Buy |
+7,241
| New | +$642K | 0.33% | 61 |
|
Other funds holding NVS
Ropes Wealth Advisors's NVS Position: Q3 2023 in Review
Ropes Wealth Advisors reduced its Novartis (NVS) stake by 5.3% in Q3 2023, selling an estimated $18.2K and leaving 3,187 shares worth $325K. The position accounts for 0.06% of the portfolio, ranked #203.
Ropes Wealth Advisors first reported a position in NVS in Q1 2015 and has held it in 35 quarters since. The position peaked at $836K in Q3 2015. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.
- Ropes Wealth Advisors held 3,187 shares of Novartis worth $325K as of Q3 2023.
- Ropes Wealth Advisors sold 179 Novartis shares in Q3 2023, an estimated $18.2K.
- Novartis made up 0.06% of Ropes Wealth Advisors's portfolio in Q3 2023, its #203 holding.
- Ropes Wealth Advisors first reported a position in Novartis in Q1 2015 and has held it in 35 quarters since.
- Ropes Wealth Advisors's Novartis position peaked at $836K in Q3 2015.
- 1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.
Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.